BPC-157

BPC-157 is a synthetic peptide sequence derived from a protein found in gastric juice, often described in the literature as a gastric pentadecapeptide or body protection compound. Research examines its role in gut barrier integrity, connective-tissue repair, and the signaling that coordinates healing. It is supplied by CoreX for laboratory research use only, and most published work on it comes from animal and preclinical studies.

Research investigates BPC-157 for its influence on angiogenic signaling and growth-factor receptor expression at sites of tissue stress. It has been studied for its relationship with VEGF-associated pathways involved in forming the microvasculature that supports repair. Separate lines of research have explored a role in maintaining the integrity of the intestinal lining under inflammatory stress. These proposed mechanisms come largely from preclinical models and are not fully characterized in humans.

Published reviews describe research on BPC-157 in musculoskeletal soft tissue healing, including tendon, ligament and muscle models, as well as wound healing and gastroprotection. Recent systematic and narrative reviews have examined its emerging use in orthopaedic sports medicine. A small human report described intra-articular injection for several types of knee pain. Overall, the evidence base is dominated by animal studies, and large controlled human trials are lacking.

Human safety data for BPC-157 are limited. Adverse events are not systematically summarized in the cited studies, and no large controlled trials have established a safety profile. A 2025 narrative review framed the topic as regeneration or risk, reflecting uncertainty about potential harms alongside proposed benefits. Reviews aimed at orthopaedic and sports medicine clinicians have also highlighted challenges and open questions surrounding injectable peptides such as BPC-157.

Research protocols have used 250 to 1,000 mcg per administration, twice daily, in 8-week blocks followed by 4 weeks off, with subcutaneous administration described. These figures reflect what protocols have reported and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. Because controlled human dose-finding studies are lacking, these ranges should be viewed in the context of a largely preclinical evidence base.